Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 289-296

  Wezel, Anouk ^a,b   Lagraauw, H Maxime ^a   van der Velden, Daniël ^a,b   de Jager, Saskia C A ^c   Quax, Paul H A ^b   Kuiper, Johan ^a   Bot, Ilze ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerotic plaque development and progression; Chemokines; Influx; Mast cells; Neutrophils; Recruitment

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR2 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4; COMPOUND 48-80; CXCL1 CHEMOKINE; IMMUNOGLOBULIN E; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; CXCL1 PROTEIN, MOUSE; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BONE MARROW DERIVED MAST CELL; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LEUKOCYTE ACTIVATION; MALE; MEDIATOR; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MAST CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA; AORTA DISEASE; ATHEROSCLEROSIS; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MAST CELL; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELLS, CULTURED; CHEMOKINE CXCL1; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; IMMUNOGLOBULIN E; MALE; MAST CELLS; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; PARACRINE COMMUNICATION; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, CXCR4; RECEPTORS, INTERLEUKIN-8B; SIGNAL TRANSDUCTION;

EID: 84936128127     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.028     Document Type: Article

References (39)

1. Murray C.J.L., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223. 10.1016/S0140-6736(12)61689-4.
2. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 2008, 8:802-815. 10.1038/nri2415.
3. Libby P., Lichtman A.H., Hansson G.K. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013, 38:1092-1104. 10.1016/j.immuni.2013.06.009.
4. Mihaylova B., Emberson J., Blackwell L., Keech A., Simes J., et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012, 380:581-590. Cholesterol Treatment Trialists' (CTT) Collaborators. 10.1016/S0140-6736(12)60367-5.
5. Bot I., de Jager S.C.A., Zernecke A., Lindstedt K.A., van Berkel T.J.C., Weber C., et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 2007, 115:2516-2525. 10.1161/CIRCULATIONAHA.106.660472.
6. Sun J., Sukhova G.K., Wolters P.J., Yang M., Kitamoto S., Libby P., et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med. 2007, 13:719-724. 10.1038/nm1601.
7. Kaartinen M., Penttilä A., Kovanen P.T. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994, 90:1669-1678.
8. Kovanen P.T., Kaartinen M., Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995, 92:1084-1088.
9. Willems S., Vink A., Bot I., Quax P.H.A., de Borst G.J., de Vries J.-P.P.M., et al. Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events. Eur. Heart J. 2013, 34:3699-3706. 10.1093/eurheartj/eht186.
10. Kovanen P.T., Mänttäri M., Palosuo T., Manninen V., Aho K. Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch. Intern. Med. 1998, 158:1434-1439.
11. Oksjoki R., Laine P., Helske S., Vehmaan-Kreula P., Mäyränpää M.I., Gasque P., et al. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques. Atherosclerosis 2007, 195:90-99. 10.1016/j.atherosclerosis.2006.12.016.
12. de Vries M.R., Wezel A., Schepers A., van Santbrink P.J., Woodruff T.M., Niessen H.W.M., et al. Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease. Cardiovasc. Res. 2013, 97:311-320. 10.1093/cvr/cvs312.
13. Laine P., Naukkarinen A., Heikkilä L., Penttilä A., Kovanen P.T. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation 2000, 101:1665-1669.
14. Bot I., de Jager S.C.A., Bot M., van Heiningen S.H., de Groot P., Veldhuizen R.W., et al. The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis. Circ. Res. 2010, 106:89-92. 10.1161/CIRCRESAHA.109.204875.
15. Lappalainen J., Lindstedt K.A., Oksjoki R., Kovanen P.T. OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells. Atherosclerosis 2011, 214:357-363. 10.1016/j.atherosclerosis.2010.11.024.
16. Bot M., de Jager S.C.A., MacAleese L., Lagraauw H.M., van Berkel T.J.C., Quax P.H.A., et al. Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation. J.Lipid Res. 2013, 54:1265-1274. 10.1194/jlr.M032862.
17. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nat. Immunol. 2008, 9:1215-1223. 10.1038/ni.f.216.
18. -/- mice. Cardiovasc. Res. 2011, 89:244-252. 10.1093/cvr/cvq260.
19. Leskinen M., Wang Y., Leszczynski D., Lindstedt K.A., Kovanen P.T. Mast cell chymase induces apoptosis of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2001, 21:516-522.
20. Lätti S., Leskinen M., Shiota N., Wang Y., Kovanen P.T., Lindstedt K.A. Mast cell-mediated apoptosis of endothelial cells invitro: a paracrine mechanism involving TNF-alpha-mediated down-regulation of bcl-2 expression. J.Cell. Physiol. 2003, 195:130-138. 10.1002/jcp.10235.
21. Kitamura D., Roes J., Kühn R., Rajewsky K. AB cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 1991, 350:423-426. 10.1038/350423a0.
22. Kyaw T., Tay C., Khan A., Dumouchel V., Cao A., To K., et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J.Immunol. Balt. Md. 2010, 1950(185):4410-4419. 10.4049/jimmunol.1000033.
23. Hasenberg M., Köhler A., Bonifatius S., Borucki K., Riek-Burchardt M., Achilles J., et al. Rapid immunomagnetic negative enrichment of neutrophil granulocytes from murine bone marrow for functional studies invitro and invivo. PLoS One 2011, 6:e17314. 10.1371/journal.pone.0017314.
24. Boxio R., Bossenmeyer-Pourié C., Steinckwich N., Dournon C., Nüße O. Mouse bone marrow contains large numbers of functionally competent neutrophils. J.Leukoc. Biol. 2004, 75:604-611. 10.1189/jlb.0703340.
25. de Jager S.C.A., Bot I., Kraaijeveld A.O., Korporaal S.J.A., Bot M., van Santbrink P.J., et al. Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation. Arterioscler. Thromb. Vasc. Biol. 2013, 33:e75-83. 10.1161/ATVBAHA.112.300857.
26. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159. 10.1006/abio.1987.9999.
27. Zhang J., Alcaide P., Liu L., Sun J., He A., Luscinskas F.W., et al. Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils. PLoS One 2011, 6:e14525. 10.1371/journal.pone.0014525.
28. Grützkau A., Krüger-Krasagakes S., Kögel H., Möller A., Lippert U., Henz B.M. Detection of intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy. J.Histochem. Cytochem. Off. J. Histochem. Soc. 1997, 45:935-945.
29. Zernecke A., Bot I., Djalali-Talab Y., Shagdarsuren E., Bidzhekov K., Meiler S., et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 2008, 102:209-217. 10.1161/CIRCRESAHA.107.160697.
30. Bot I., Daissormont I.T.M.N., Zernecke A., van Puijvelde G.H.M., Kramp B., de Jager S.C.A., et al. CXCR4 blockade induces atherosclerosis by affecting neutrophil function. J.Mol. Cell. Cardiol. 2014, 74:44-52. 10.1016/j.yjmcc.2014.04.021.
31. De Filippo K., Dudeck A., Hasenberg M., Nye E., van Rooijen N., Hartmann K., et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 2013, 121:4930-4937. 10.1182/blood-2013-02-486217.
32. Christy A.L., Walker M.E., Hessner M.J., Brown M.A. Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J.Autoimmun. 2013, 42:50-61. 10.1016/j.jaut.2012.11.003.
33. Schramm R., Schaefer T., Menger M.D., Thorlacius H. Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J.Leukoc. Biol. 2002, 72:1122-1132.
34. Shin K., Nigrovic P.A., Crish J., Boilard E., McNeil H.P., Larabee K.S., et al. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J.Immunol. Balt. Md. 2009, 1950(182):647-656.
35. Drechsler M., Megens R.T.A., van Zandvoort M., Weber C., Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010, 122:1837-1845. 10.1161/CIRCULATIONAHA.110.961714.
36. -/- mice. Am. J. Pathol. 2010, 177:493-500. 10.2353/ajpath.2010.090480.
37. Ionita M.G., van den Borne P., Catanzariti L.M., Moll F.L., de Vries J.-P.P.M., Pasterkamp G., et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1842-1848. 10.1161/ATVBAHA.110.209296.
38. Borissoff J.I., Joosen I.A., Versteylen M.O., Brill A., Fuchs T.A., Savchenko A.S., et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler. Thromb. Vasc. Biol. 2013, 33:2032-2040. 10.1161/ATVBAHA.113.301627.
39. Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ. Res. 2012, 110:875-888. 10.1161/CIRCRESAHA.111.257535.